Healthcare Providers and Services
Company Overview of Fresenius Medical Care Holdings Inc.
Fresenius Medical Care Holdings Inc., doing business as Fresenius Medical Care North America, provides kidney dialysis and renal services in North America. It manufactures and distributes various dialysis equipment, including dialysis machines and disposables, dialyzers, bloodlines, and concentrates, as well as renal pharmaceuticals. The company also provides home therapies services, such as peritoneal dialysis and home hemodialysis services; and patient care, vascular care, and pharmacy services. In addition, it offers laboratory products and services in the renal industry; inpatient dialysis treatment services; and dialysis treatment therapies, therapeutic apheresis therapies, and quality ...
920 Winter Street
Waltham, MA 02451-1457
Key Executives for Fresenius Medical Care Holdings Inc.
Senior Vice President of Operations and President of West Division
Deputy Chairman of The Management Board and Chief Executive Officer of Fresenius Medical Care North America
Chief Executive Officer of Extracorporeal Alliance
Compensation as of Fiscal Year 2014.
Fresenius Medical Care Holdings Inc. Key Developments
Fresenius Medical Care Holdings Inc. Wins $1,046,013.12 Federal Contract
Jan 27 15
Fresenius Medical Care Holdings Inc., Waltham, Massachusetts, won a $1,046,013.12 federal contract from the U.S. Department of Veterans Affairs' Hampton Medical Center, Hampton, Virginia, for inpatient dialysis services.
Fresenius Medical Care North America Announces Voluntary Recall of 56 Lots of NaturaLyte(R) Liquid Bicarbonate Concentrate
May 21 14
Fresenius Medical Care North America announced that its voluntary recall of 56 lots of NaturaLyte(R) Liquid Bicarbonate Concentrate, 6.4 liters (intended for use in hemodialysis machines) from distribution has been classified as a Class 1 Recall. The affected lots were produced in its Montreal, Canada facility and are being recalled because they may develop higher bacteria levels than is allowed by the company's internal specification during their shelf life. Laboratory testing has identified the bacteria as Halomonas (species 1, 2, 3), a Gram Negative bacteria, typically found in water with high salinity (salt concentration). According to a few case reports in the medical literature, bacterial contamination of the dialysate may lead to bacteremia or systemic infection. The dialysis filter (dialyzer) and the use of the Diasafe(TM) filter or equivalent create an effective bacteria and endotoxin barrier that makes this event unlikely.
Fresenius Medical Care Renal Therapies Group Announces Executive Changes
Apr 8 14
Fresenius Medical Care Renal Therapies Group (RTG) announced that Dr. Jose A. Diaz-Buxo, Chief Medical Officer and Senior Vice President, has decided to retire as of May 31, 2014. Dr. Robert Kossmann will assume this position beginning July 1, 2014. Dr. Diaz-Buxo joined Fresenius Medical Care North America (FMCNA) in 1996 as president of the company's Peritoneal Dialysis Services and was named RTG's Chief Medical Officer in 2004. RTG has named Dr. Robert Kossmann as its incoming Chief Medical Officer. He will assume this position following Dr. Diaz-Buxo's retirement. Dr. Kossmann is a nephrologist in Santa Fe, N.M., a member of the volunteer clinical faculty at the University of New Mexico's Department of Medicine, and has served extensively in the renal care field. His roles have included; President of the Renal Physicians Association, nephrology advisor to the American Medical Association's Relative Value Scale Update Committee, founding member of the Nephrology Coverage Advocacy Program, and founder of the New Mexico Renal Disease Collaborative Group.
Similar Private Companies By Industry
Recent Private Companies Transactions